Genscript on Bioeconhttps://en.bioecon.ru/companies/genscript/Recent content in Genscript on BioeconHugoen-USSun, 26 Jul 2026 00:43:44 +0700iGEM infrastructure, BioBricks and standard genetic partshttps://en.bioecon.ru/technology/igem-infrastructure-biobricks-standard-genetic-parts/Sat, 25 Jul 2026 17:20:00 +0000https://en.bioecon.ru/technology/igem-infrastructure-biobricks-standard-genetic-parts/The shared substrate synthetic biology runs on — a registry of standard parts and the student competition that populates it, nonprofit plasmid repositories, commercial gene synthesis reaching 7,000 base pairs on complex sequences, and automated biofoundries whose assemblies are now validated by long-read sequencing.Strain engineering (synbio CRO)https://en.bioecon.ru/technology/strain-engineering-synbio-cro/Sat, 25 Jul 2026 15:40:00 +0000https://en.bioecon.ru/technology/strain-engineering-synbio-cro/Contract organisations that engineer the microbe or enzyme itself — directed evolution, computational protein design and genome editing of production strains — delivering measured process gains such as a substrate loading raised from 5 to 67 g/L and enzyme load cut from 100 to 3 weight percent, rather than selling a molecule.DNA synthesis & gene foundryhttps://en.bioecon.ru/technology/dna-synthesis-gene-foundry/Thu, 23 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/dna-synthesis-gene-foundry/The commercial gene-synthesis service and biofoundry layer of synthetic biology — turning digital DNA designs into delivered genes, clones and strain builds through phosphoramidite and emerging enzymatic synthesis, governed by pathogen-sequence biosecurity screening.CRISPR screening as a servicehttps://en.bioecon.ru/technology/crispr-screening-as-a-service/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/crispr-screening-as-a-service/Contract functional-genetic CRISPR screening (pooled sgRNA libraries, lentiviral delivery, NGS) — identifies cancer-resistance genes and drug targets in weeks.Gene therapyhttps://en.bioecon.ru/technology/gene-therapy/Mon, 01 Jan 0001 00:00:00 +0000https://en.bioecon.ru/technology/gene-therapy/Precision delivery of functional genetic material via engineered vectors to treat inherited diseases and severe genetic disorders at their root cause.